Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer



Date of IPO


Market Cap


About Neuroscientific Biopharmaceuticals

Neuroscientific Biopharmaceuticals is committed to developing pharmaceutical solutions for neurological disorders.

Neuroscientific Biopharmaceuticals Headquarter Location

Level 1 45 Stirling Highway

Nedlands, Western Australia, 6009,


Latest Neuroscientific Biopharmaceuticals News

NeuroScientific Biopharmaceuticals: Launches post-COVID fibrosis research program

Nov 21, 2020

NeuroScientific Biopharmaceuticals is teaming up with the Institute of Respiratory Health and the University of Western Australia to find a treatment for post-COVID fibrosis Then the disease can cause lasting damage to the lungs, even in young adults, and could potentially become one of the largest future burdens on global healthcare However, recent data has shown that a protein known as Metallothionein can protect the lungs from injury and fibrosis This is where NSB comes in: its flagship candidate, EmtinB, designed to mimic the protein in patients NSB and UWA’s will now research the protein and its viability as a post-COVID fibrosis treatment, with data set for release in the first half of 2021 On the market this afternoon, NSB remains steady and is trading for 34 cents per share Tags:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Neuroscientific Biopharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Neuroscientific Biopharmaceuticals is included in 1 Expert Collection, including Neuroscience.



2,144 items

Companies developing products that monitor, analyze, protect, or otherwise influence the structure/function of the nervous system.

Neuroscientific Biopharmaceuticals Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Neuroscientific Biopharmaceuticals Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.